PER percheron therapeutics limited

Ann: Change in substantial holding, page-22

  1. 3,362 Posts.
    lightbulb Created with Sketch. 274
    PER was not valued 200M$ which is what DXB was before failed trial. PER was 60M$ very cheap for drug in Ph2b with 20M$ cash. yes drug failed but there lot more indications ahead and i am still optimistic that jan results may reveal something interesting. happy to hold and wait given cash in hand, no CR for unforseable future and interesting news in Jan to see what company forward plans aee
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $727 72.68K

Buyers (Bids)

No. Vol. Price($)
4 2840316 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3323423 6
View Market Depth
Last trade - 12.00pm 20/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.